LivingGLP1
parallel randomized trial

NCT06256562

A Multicenter, Randomized, Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Chinese Obese/Overweight Patients

Design

Randomized
340
Start year
2023
Treatment
30 weeks, follow-up 33 weeks
Countries
China (20 sites)
Sponsor
Gan & Lee Pharmaceuticals (industry)
Eligibility
age 18 to 75; BMI 24 to <28 kg/m2 with comorbidity or 28 or more (Chinese criteria); no diabetes

Conduct and analysis

Blinding
double blind
Sequence generation
computer
Allocation concealment
central
Outcome adjudication
not reported
Primary estimand
treatment policy
Analysis population
modified itt
Missing data
multiple imputation

Arms

ArmTreatmentBackgroundRandomizedAnalyzedCompleted treatment
A1Bofanglutide 12 mg injection every 2 weeks
Bofanglutide 12 mg Q2W
lifestyle: standard5252
A2Bofanglutide 18 mg injection every 2 weeks
Bofanglutide 18 mg Q2W
lifestyle: standard5353
A3Bofanglutide 24 mg injection every 2 weeks
Bofanglutide 24 mg Q2W
lifestyle: standard5252
A4Bofanglutide 48 mg injection every 2 weeks
Bofanglutide 48 mg Q2W
lifestyle: standard6464
A5Bofanglutide 24 mg injection once weekly
Bofanglutide 24 mg QW
lifestyle: standard5353
A6Placebo
Placebo
lifestyle: standard6666

Baseline characteristics

As printed in the trial reports or registry, per arm or for the whole trial.
CharacteristicStatisticBofanglutide 12 mg injection every 2 weeks
A1
Bofanglutide 18 mg injection every 2 weeks
A2
Bofanglutide 24 mg injection every 2 weeks
A3
Bofanglutide 48 mg injection every 2 weeks
A4
Bofanglutide 24 mg injection once weekly
A5
Placebo
A6
agemean (years)32.333.033.732.832.833.7
agesd (years)7.07.66.37.87.47.2
asiann525352645366
asianpercent100100100100100100
bmi: 24 to less than 28n153855
bmi: 24 to less than 28percent1.99.45.812.59.47.6
bmi: 28 or moren514849564861
bmi: 28 or morepercent98.190.694.287.590.692.4
bmimean (kg/m2)33.732.433.333.033.133.8
bmisd (kg/m2)4.94.14.14.94.55.0
femalen202620352331
femalepercent38.549.138.554.743.447.0
hba1cmean (percent)5.605.485.575.545.675.62
hba1csd (percent)0.390.410.420.340.490.37
sbpmean (mmHg)122.5121.5122.9123.4119.9119.7
sbpsd (mmHg)9.6011.4110.5310.3711.4410.31
waistmean (cm)107.7105.1108.1105.5106.3108.2
waistsd (cm)13.211.211.014.012.213.1
weightmean (kg)97.2293.0197.1794.8794.5296.90
weightsd (kg)21.2214.5917.2223.1718.6021.46

Analyses this trial contributes to

Results

228 adjudicated result lines, grouped by outcome. Open an outcome to see its values.
Systolic blood pressure change (11 lines; O05)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
30A1 vs A6md-3.31 mmHg-7.47 to 0.84treatment policy; modified itt; R0002409:Supplement Table S4
30A1change-3.42 mmHg1.5652treatment policy; modified itt; R0002409:Supplement Table S4
30A2change-8.13 mmHg1.5153treatment policy; modified itt; R0002409:Supplement Table S4
30A2 vs A6md-8.03 mmHg-12.17 to -3.89treatment policy; modified itt; R0002409:Supplement Table S4
30A3change-4.82 mmHg1.5852treatment policy; modified itt; R0002409:Supplement Table S4
30A3 vs A6md-4.71 mmHg-8.84 to -0.58treatment policy; modified itt; R0002409:Supplement Table S4
30A4 vs A6md-10.05 mmHg-14.12 to -5.98treatment policy; modified itt; R0002409:Supplement Table S4
30A4change-10.16 mmHg1.5464treatment policy; modified itt; R0002409:Supplement Table S4
30A5 vs A6md-6.85 mmHg-11.16 to -2.53treatment policy; modified itt; R0002409:Supplement Table S4
30A5change-6.95 mmHg1.6453treatment policy; modified itt; R0002409:Supplement Table S4
30A6change-0.10 mmHg1.5466treatment policy; modified itt; R0002409:Supplement Table S4
Percent body weight change (74 lines; O10)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
30A1percent change-11.15 percent1.0441not stated; per protocol; R0002409:Supplement Table S2
30A1percent change-9.98 percent0.94not stated; modified itt; R0002409:Supplement Table S2
30A1 vs A6md-8.57 percent-11.03 to -6.10not stated; modified itt; R0002409:Supplement Table S2
30A1 vs A6md-10.17 percent-12.86 to -7.47not stated; per protocol; R0002409:Supplement Table S2
30A1 vs A6md-9.05 percent-11.50 to -6.59not stated; modified itt; R0002409:Supplement Table S2
30A1 vs A6md-8.60 percent-11.18 to -6.01treatment policy; modified itt; R0002409:Table 2
30A1percent change-0.94 percent-22.30 to 20.41treatment policy; modified itt; bmi:24_to_less_than_27; R0002409:Supplement Table S3
30A1percent change-10.25 percent-12.34 to -8.15treatment policy; modified itt; bmi:30_or_more; R0002409:Supplement Table S3
30A1percent change-9.75 percent0.9952treatment policy; modified itt; R0002409:Table 2
30A1percent change-7.79 percent-10.08 to -5.49treatment policy; modified itt; sex:male; R0002409:Supplement Table S3
30A1percent change-12.65 percent-16.00 to -9.29treatment policy; modified itt; sex:female; R0002409:Supplement Table S3
30A1percent change-7.83 percent-12.61 to -3.05treatment policy; modified itt; bmi:27_to_less_than_30; R0002409:Supplement Table S3
30A1percent change-9.72 percent0.94not stated; modified itt; R0002409:Supplement Table S2
30A2percent change-11.59 percent-13.75 to -9.43treatment policy; modified itt; bmi:30_or_more; R0002409:Supplement Table S3
30A2percent change-15.45 percent-19.45 to -11.45treatment policy; modified itt; bmi:27_to_less_than_30; R0002409:Supplement Table S3
30A2percent change-14.02 percent-24.48 to -3.57treatment policy; modified itt; bmi:24_to_less_than_27; R0002409:Supplement Table S3
30A2percent change-12.50 percent0.93not stated; modified itt; R0002409:Supplement Table S2
30A2percent change-13.22 percent0.9549not stated; per protocol; R0002409:Supplement Table S2
30A2percent change-12.74 percent0.91not stated; modified itt; R0002409:Supplement Table S2
30A2 vs A6md-11.35 percent-13.80 to -8.89not stated; modified itt; R0002409:Supplement Table S2
30A2 vs A6md-12.23 percent-14.80 to -9.67not stated; per protocol; R0002409:Supplement Table S2
30A2 vs A6md-11.81 percent-14.22 to -9.39not stated; modified itt; R0002409:Supplement Table S2
30A2percent change-11.85 percent-14.33 to -9.37treatment policy; modified itt; sex:male; R0002409:Supplement Table S3
30A2percent change-13.52 percent-16.35 to -10.68treatment policy; modified itt; sex:female; R0002409:Supplement Table S3
30A2percent change-12.55 percent0.9653treatment policy; modified itt; R0002409:Table 2
30A2 vs A6md-11.39 percent-13.92 to -8.87treatment policy; modified itt; R0002409:Table 2
30A3 vs A6md-12.19 percent-14.65 to -9.73not stated; modified itt; R0002409:Supplement Table S2
30A3percent change-14.85 percent-18.08 to -11.62treatment policy; modified itt; sex:female; R0002409:Supplement Table S3
30A3 vs A6md-12.50 percent-15.07 to -9.94treatment policy; modified itt; R0002409:Table 2
30A3percent change-13.82 percent0.93not stated; modified itt; R0002409:Supplement Table S2
30A3percent change-14.25 percent1.0143not stated; per protocol; R0002409:Supplement Table S2
30A3percent change-13.40 percent-15.52 to -11.27treatment policy; modified itt; bmi:30_or_more; R0002409:Supplement Table S3
30A3percent change-13.34 percent0.94not stated; modified itt; R0002409:Supplement Table S2
30A3percent change-22.70 percent-34.79 to -10.61treatment policy; modified itt; bmi:24_to_less_than_27; R0002409:Supplement Table S3
30A3percent change-13.86 percent-18.37 to -9.35treatment policy; modified itt; bmi:27_to_less_than_30; R0002409:Supplement Table S3
30A3 vs A6md-12.89 percent-15.32 to -10.45not stated; modified itt; R0002409:Supplement Table S2
30A3 vs A6md-13.27 percent-15.93 to -10.61not stated; per protocol; R0002409:Supplement Table S2
30A3percent change-12.86 percent-15.15 to -10.57treatment policy; modified itt; sex:male; R0002409:Supplement Table S3
30A3percent change-13.66 percent0.9752treatment policy; modified itt; R0002409:Table 2
30A4percent change-16.04 percent-18.19 to -13.89treatment policy; modified itt; bmi:30_or_more; R0002409:Supplement Table S3
30A4percent change-15.09 percent0.84not stated; modified itt; R0002409:Supplement Table S2
30A4percent change-17.29 percent0.9945not stated; per protocol; R0002409:Supplement Table S2
30A4percent change-17.57 percent0.87not stated; modified itt; R0002409:Supplement Table S2
30A4 vs A6md-13.94 percent-16.27 to -11.61not stated; modified itt; R0002409:Supplement Table S2
30A4 vs A6md-16.30 percent-18.93 to -13.68not stated; per protocol; R0002409:Supplement Table S2
30A4 vs A6md-16.64 percent-19.00 to -14.28not stated; modified itt; R0002409:Supplement Table S2
30A4percent change-16.09 percent0.9464treatment policy; modified itt; R0002409:Table 2
30A4 vs A6md-14.94 percent-17.45 to -12.42treatment policy; modified itt; R0002409:Table 2
30A4percent change-17.74 percent-23.57 to -11.92treatment policy; modified itt; bmi:24_to_less_than_27; R0002409:Supplement Table S3
30A4percent change-16.01 percent-20.41 to -11.61treatment policy; modified itt; bmi:27_to_less_than_30; R0002409:Supplement Table S3
30A4percent change-16.94 percent-19.59 to -14.29treatment policy; modified itt; sex:female; R0002409:Supplement Table S3
30A4percent change-15.03 percent-17.61 to -12.44treatment policy; modified itt; sex:male; R0002409:Supplement Table S3
30A5percent change-16.86 percent-25.67 to -8.04treatment policy; modified itt; bmi:24_to_less_than_27; R0002409:Supplement Table S3
30A5percent change-18.82 percent-21.91 to -15.73treatment policy; modified itt; sex:female; R0002409:Supplement Table S3
30A5 vs A6md-15.54 percent-18.10 to -12.98treatment policy; modified itt; R0002409:Table 2
30A5percent change-17.30 percent0.93not stated; modified itt; R0002409:Supplement Table S2
30A5percent change-17.78 percent1.0143not stated; per protocol; R0002409:Supplement Table S2
30A5percent change-16.28 percent0.93not stated; modified itt; R0002409:Supplement Table S2
30A5percent change-16.69 percent0.9853treatment policy; modified itt; R0002409:Table 2
30A5percent change-15.10 percent-17.48 to -12.72treatment policy; modified itt; sex:male; R0002409:Supplement Table S3
30A5percent change-16.36 percent-18.58 to -14.14treatment policy; modified itt; bmi:30_or_more; R0002409:Supplement Table S3
30A5percent change-17.69 percent-21.79 to -13.59treatment policy; modified itt; bmi:27_to_less_than_30; R0002409:Supplement Table S3
30A5 vs A6md-16.37 percent-18.81 to -13.93not stated; modified itt; R0002409:Supplement Table S2
30A5 vs A6md-16.80 percent-19.45 to -14.14not stated; per protocol; R0002409:Supplement Table S2
30A5 vs A6md-15.12 percent-17.57 to -12.67not stated; modified itt; R0002409:Supplement Table S2
30A6percent change-1.15 percent0.8766treatment policy; modified itt; R0002409:Table 2
30A6percent change1.85 percent-2.14 to 5.85treatment policy; modified itt; bmi:27_to_less_than_30; R0002409:Supplement Table S3
30A6percent change-0.93 percent0.83not stated; modified itt; R0002409:Supplement Table S2
30A6percent change-0.99 percent0.9153not stated; per protocol; R0002409:Supplement Table S2
30A6percent change-1.16 percent0.83not stated; modified itt; R0002409:Supplement Table S2
30A6percent change-2.07 percent-4.00 to -0.14treatment policy; modified itt; bmi:30_or_more; R0002409:Supplement Table S3
30A6percent change-1.18 percent-3.86 to 1.50treatment policy; modified itt; sex:female; R0002409:Supplement Table S3
30A6percent change3.29 percent-3.86 to 10.45treatment policy; modified itt; bmi:24_to_less_than_27; R0002409:Supplement Table S3
30A6percent change-1.11 percent-3.29 to 1.07treatment policy; modified itt; sex:male; R0002409:Supplement Table S3
Weight loss of 5 percent or more (11 lines; O11A)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
30A1responders74.052treatment policy; modified itt; R0002409:Table 2
30A1 vs A6rd58.443.5 to 73.3treatment policy; modified itt; R0002409:Table 2
30A2responders87.553treatment policy; modified itt; R0002409:Table 2
30A2 vs A6rd71.758.8 to 84.6treatment policy; modified itt; R0002409:Table 2
30A3responders89.152treatment policy; modified itt; R0002409:Table 2
30A3 vs A6rd73.762.1 to 85.4treatment policy; modified itt; R0002409:Table 2
30A4responders96.864treatment policy; modified itt; R0002409:Table 2
30A4 vs A6rd81.672.5 to 90.7treatment policy; modified itt; R0002409:Table 2
30A5 vs A6rd77.265.6 to 88.8treatment policy; modified itt; R0002409:Table 2
30A5responders93.053treatment policy; modified itt; R0002409:Table 2
30A6responders18.566treatment policy; modified itt; R0002409:Table 2
Weight loss of 10 percent or more (11 lines; O11B)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
30A1responders51.952treatment policy; modified itt; R0002409:Table 2
30A1 vs A6rd46.032.7 to 59.2treatment policy; modified itt; R0002409:Table 2
30A2responders62.253treatment policy; modified itt; R0002409:Table 2
30A2 vs A6rd55.842.5 to 69.0treatment policy; modified itt; R0002409:Table 2
30A3responders74.752treatment policy; modified itt; R0002409:Table 2
30A3 vs A6rd68.954.7 to 83.2treatment policy; modified itt; R0002409:Table 2
30A4responders82.764treatment policy; modified itt; R0002409:Table 2
30A4 vs A6rd81.370.4 to 92.3treatment policy; modified itt; R0002409:Table 2
30A5responders88.753treatment policy; modified itt; R0002409:Table 2
30A5 vs A6rd82.171.4 to 92.9treatment policy; modified itt; R0002409:Table 2
30A6responders6.766treatment policy; modified itt; R0002409:Table 2
Weight loss of 15 percent or more (11 lines; O11C)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
30A1responders25.752treatment policy; modified itt; R0002409:Table 2
30A1 vs A6rd20.17.5 to 32.7treatment policy; modified itt; R0002409:Table 2
30A2responders36.453treatment policy; modified itt; R0002409:Table 2
30A2 vs A6rd32.520.3 to 44.7treatment policy; modified itt; R0002409:Table 2
30A3responders42.452treatment policy; modified itt; R0002409:Table 2
30A3 vs A6rd37.622.5 to 52.8treatment policy; modified itt; R0002409:Table 2
30A4 vs A6rd59.246.2 to 72.2treatment policy; modified itt; R0002409:Table 2
30A4responders61.564treatment policy; modified itt; R0002409:Table 2
30A5responders64.553treatment policy; modified itt; R0002409:Table 2
30A5 vs A6rd60.747.2 to 74.1treatment policy; modified itt; R0002409:Table 2
30A6responders3.966treatment policy; modified itt; R0002409:Table 2
Weight loss of 20 percent or more (11 lines; O11D)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
30A1responders9.052treatment policy; modified itt; R0002409:Table 2
30A1 vs A6rd4.7-5.6 to 15.0treatment policy; modified itt; R0002409:Table 2
30A2responders16.753treatment policy; modified itt; R0002409:Table 2
30A2 vs A6rd13.63.9 to 23.3treatment policy; modified itt; R0002409:Table 2
30A3responders19.452treatment policy; modified itt; R0002409:Table 2
30A3 vs A6rd16.74.7 to 28.8treatment policy; modified itt; R0002409:Table 2
30A4responders39.264treatment policy; modified itt; R0002409:Table 2
30A4 vs A6rd37.323.9 to 50.6treatment policy; modified itt; R0002409:Table 2
30A5responders37.353treatment policy; modified itt; R0002409:Table 2
30A5 vs A6rd34.320.1 to 48.4treatment policy; modified itt; R0002409:Table 2
30A6responders3.566treatment policy; modified itt; R0002409:Table 2
All cause mortality (6 lines; O20)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
A1events0 / 52not stated; safety; R0002409:Table 3
A2events0 / 53not stated; safety; R0002409:Table 3
A3events0 / 52not stated; safety; R0002409:Table 3
A4events0 / 64not stated; safety; R0002409:Table 3
A5events0 / 53not stated; safety; R0002409:Table 3
A6events0 / 66not stated; safety; R0002409:Table 3
Hospitalization for heart failure (1 lines; O23)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
A4events0 / 64not stated; safety; R0002409:Table 3
SF-36 physical component summary change (11 lines; O24A)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
30A1change2.99 points0.5752treatment policy; modified itt; R0002409:Supplement Table S5
30A1 vs A6md1.32 points-0.18 to 2.82treatment policy; modified itt; R0002409:Supplement Table S5
30A2change3.77 points0.54453treatment policy; modified itt; R0002409:Supplement Table S5
30A2 vs A6md2.10 points0.65 to 3.55treatment policy; modified itt; R0002409:Supplement Table S5
30A3change3.23 points0.5552treatment policy; modified itt; R0002409:Supplement Table S5
30A3 vs A6md1.56 points0.10 to 3.02treatment policy; modified itt; R0002409:Supplement Table S5
30A4change2.73 points0.5464treatment policy; modified itt; R0002409:Supplement Table S5
30A4 vs A6md1.06 points-0.40 to 2.52treatment policy; modified itt; R0002409:Supplement Table S5
30A5change1.93 points0.5753treatment policy; modified itt; R0002409:Supplement Table S5
30A5 vs A6md0.26 points-1.24 to 1.77treatment policy; modified itt; R0002409:Supplement Table S5
30A6change1.67 points0.5066treatment policy; modified itt; R0002409:Supplement Table S5
Physical functioning (any instrument) (22 lines; O24B)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
30A1change8.8 points1.6852treatment policy; modified itt; R0002409:Supplement Table S5
30A1change2.36 points0.5652treatment policy; modified itt; R0002409:Supplement Table S5
30A1 vs A6md2.3 points-2.0 to 6.6treatment policy; modified itt; R0002409:Supplement Table S5
30A1 vs A6md1.35 points-0.13 to 2.83treatment policy; modified itt; R0002409:Supplement Table S5
30A2change11.4 points1.5453treatment policy; modified itt; R0002409:Supplement Table S5
30A2change3.08 points0.5353treatment policy; modified itt; R0002409:Supplement Table S5
30A2 vs A6md4.9 points0.8 to 8.9treatment policy; modified itt; R0002409:Supplement Table S5
30A2 vs A6md2.07 points0.66 to 3.47treatment policy; modified itt; R0002409:Supplement Table S5
30A3change11.4 points1.5552treatment policy; modified itt; R0002409:Supplement Table S5
30A3change3.17 points0.5352treatment policy; modified itt; R0002409:Supplement Table S5
30A3 vs A6md4.9 points0.8 to 9.0treatment policy; modified itt; R0002409:Supplement Table S5
30A3 vs A6md2.16 points0.74 to 3.58treatment policy; modified itt; R0002409:Supplement Table S5
30A4change8.9 points1.7864treatment policy; modified itt; R0002409:Supplement Table S5
30A4change2.92 points0.5564treatment policy; modified itt; R0002409:Supplement Table S5
30A4 vs A6md2.4 points-2.1 to 6.8treatment policy; modified itt; R0002409:Supplement Table S5
30A4 vs A6md1.91 points0.44 to 3.38treatment policy; modified itt; R0002409:Supplement Table S5
30A5change7.5 points1.6253treatment policy; modified itt; R0002409:Supplement Table S5
30A5change1.86 points0.5453treatment policy; modified itt; R0002409:Supplement Table S5
30A5 vs A6md1.0 points-3.2 to 5.1treatment policy; modified itt; R0002409:Supplement Table S5
30A5 vs A6md0.86 points-0.61 to 2.32treatment policy; modified itt; R0002409:Supplement Table S5
30A6change6.6 points1.3966treatment policy; modified itt; R0002409:Supplement Table S5
30A6change1.01 points0.4966treatment policy; modified itt; R0002409:Supplement Table S5
Health related quality of life total score (any instrument) (11 lines; O24C)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
30A1change10.61 points1.6552treatment policy; modified itt; R0002409:Supplement Table S5
30A1 vs A6md2.58 points-1.63 to 6.78treatment policy; modified itt; R0002409:Supplement Table S5
30A2change12.57 points1.5253treatment policy; modified itt; R0002409:Supplement Table S5
30A2 vs A6md4.53 points0.52 to 8.54treatment policy; modified itt; R0002409:Supplement Table S5
30A3change12.68 points1.5552treatment policy; modified itt; R0002409:Supplement Table S5
30A3 vs A6md4.65 points0.59 to 8.70treatment policy; modified itt; R0002409:Supplement Table S5
30A4change11.05 points1.7364treatment policy; modified itt; R0002409:Supplement Table S5
30A4 vs A6md3.01 points-1.37 to 7.40treatment policy; modified itt; R0002409:Supplement Table S5
30A5change8.45 points1.6253treatment policy; modified itt; R0002409:Supplement Table S5
30A5 vs A6md0.42 points-3.73 to 4.56treatment policy; modified itt; R0002409:Supplement Table S5
30A6change8.03 points1.3866treatment policy; modified itt; R0002409:Supplement Table S5
Serious adverse events (6 lines; O25)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
A1events2 / 52not stated; safety; R0002409:Table 3
A2events3 / 53not stated; safety; R0002409:Table 3
A3events1 / 52not stated; safety; R0002409:Table 3
A4events0 / 64not stated; safety; R0002409:Table 3
A5events2 / 53not stated; safety; R0002409:Table 3
A6events1 / 66not stated; safety; R0002409:Table 3
Discontinuation due to adverse events (6 lines; O26)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
A1events4 / 52not stated; safety; R0002409:Table 3
A2events1 / 53not stated; safety; R0002409:Table 3
A3events4 / 52not stated; safety; R0002409:Table 3
A4events10 / 64not stated; safety; R0002409:Table 3
A5events5 / 53not stated; safety; R0002409:Table 3
A6events3 / 66not stated; safety; R0002409:Table 3
Nausea (6 lines; O27A)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
A1events18 / 52not stated; safety; R0002409:Table 3
A2events25 / 53not stated; safety; R0002409:Table 3
A3events25 / 52not stated; safety; R0002409:Table 3
A4events41 / 64not stated; safety; R0002409:Table 3
A5events20 / 53not stated; safety; R0002409:Table 3
A6events6 / 66not stated; safety; R0002409:Table 3
Vomiting (6 lines; O27B)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
A1events13 / 52not stated; safety; R0002409:Table 3
A2events15 / 53not stated; safety; R0002409:Table 3
A3events24 / 52not stated; safety; R0002409:Table 3
A4events40 / 64not stated; safety; R0002409:Table 3
A5events28 / 53not stated; safety; R0002409:Table 3
A6events8 / 66not stated; safety; R0002409:Table 3
Diarrhea (6 lines; O27C)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
A1events14 / 52not stated; safety; R0002409:Table 3
A2events19 / 53not stated; safety; R0002409:Table 3
A3events22 / 52not stated; safety; R0002409:Table 3
A4events24 / 64not stated; safety; R0002409:Table 3
A5events26 / 53not stated; safety; R0002409:Table 3
A6events12 / 66not stated; safety; R0002409:Table 3
Acute pancreatitis (6 lines; O29)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
A1events0 / 52not stated; safety; pancreatitis; R0002409:Results
A2events0 / 53not stated; safety; pancreatitis; R0002409:Results
A3events0 / 52not stated; safety; pancreatitis; R0002409:Results
A4events0 / 64not stated; safety; pancreatitis; R0002409:Results
A5events0 / 53not stated; safety; pancreatitis; R0002409:Results
A6events0 / 66not stated; safety; pancreatitis; R0002409:Results
Suicidal ideation or behavior (6 lines; O35A)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
A1events0 / 52not stated; safety; R0002409:Results
A2events0 / 53not stated; safety; R0002409:Results
A3events0 / 52not stated; safety; R0002409:Results
A4events0 / 64not stated; safety; R0002409:Results
A5events0 / 53not stated; safety; R0002409:Results
A6events0 / 66not stated; safety; R0002409:Results
Death by suicide (6 lines; O35B)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
A1events0 / 52not stated; safety; R0002409:Table 3
A2events0 / 53not stated; safety; R0002409:Table 3
A3events0 / 52not stated; safety; R0002409:Table 3
A4events0 / 64not stated; safety; R0002409:Table 3
A5events0 / 53not stated; safety; R0002409:Table 3
A6events0 / 66not stated; safety; R0002409:Table 3